Medtech Industry Backs Two-Speed EU MDR Revision And Rapid Changes

We do not want the commission to wait for its targeted evaluation before making regulatory changes to the MDR and IVDR, medtech industry representatives tell Galway meeting. They shared their vision of what could happen next.

Businessman overtaking businessman climbing stairs using rocket engine. Career progress
• Source: Shutterstock/ bizvector

The European Commission’s targeted evaluation of the Medical Device and IVD Regulations aims to address the challenges faced by the medtech industry. However, the European Parliament is urging quicker action.

Industry experts at the Market Access 2024 conference, in Galway, Ireland, identified potential areas for immediate improvement, such as streamlining...

More from Europe

More from Policy & Regulation

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

Commission Decision Launches Pediatric And Rare Disease Expert Group

 

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.